These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 17393453

  • 1. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
    Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Llorente L, Sánchez-Guerrero J.
    Arthritis Rheum; 2007 Apr; 56(4):1242-50. PubMed ID: 17393453
    [Abstract] [Full Text] [Related]

  • 2. Inflammatory profile in cerebrospinal fluid of patients with headache as a manifestation of neuropsychiatric systemic lupus erythematosus.
    Fragoso-Loyo H, Atisha-Fregoso Y, Llorente L, Sánchez-Guerrero J.
    Rheumatology (Oxford); 2013 Dec; 52(12):2218-22. PubMed ID: 24026247
    [Abstract] [Full Text] [Related]

  • 3. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
    Fragoso-Loyo H, Atisha-Fregoso Y, Núñez-Alvarez CA, Llorente L, Sánchez-Guerrero J.
    J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
    [Abstract] [Full Text] [Related]

  • 4. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
    Yoshio T, Okamoto H, Kurasawa K, Dei Y, Hirohata S, Minota S.
    Lupus; 2016 Aug; 25(9):997-1003. PubMed ID: 26846690
    [Abstract] [Full Text] [Related]

  • 5. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J, Kłak M, Trysberg E, Blennow K, Tarkowski A, Jin T.
    Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
    [Abstract] [Full Text] [Related]

  • 6. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H, Cabiedes J, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Diamond B, Llorente L, Sánchez-Guerrero J.
    PLoS One; 2008 Oct 06; 3(10):e3347. PubMed ID: 18836530
    [Abstract] [Full Text] [Related]

  • 7. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
    Arthritis Rheum; 2005 Jun 06; 52(6):1670-5. PubMed ID: 15934075
    [Abstract] [Full Text] [Related]

  • 8. Clinical analysis of cerebrospinal fluid interleukin-6 in neuropsychiatric systemic lupus erythematosus.
    Horai Y, Watanabe H, Miyamura T, Takahama S, Hirata A, Nakamura M, Ando H, Minami R, Yamamoto M, Suematsu E.
    Fukuoka Igaku Zasshi; 2010 Feb 06; 101(2):34-40. PubMed ID: 20560477
    [Abstract] [Full Text] [Related]

  • 9. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus.
    Iikuni N, Okamoto H, Yoshio T, Sato E, Kamitsuji S, Iwamoto T, Momohara S, Taniguchi A, Yamanaka H, Minota S, Kamatani N.
    Ann Rheum Dis; 2006 Feb 06; 65(2):253-6. PubMed ID: 16410530
    [Abstract] [Full Text] [Related]

  • 10. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H, Atisha-Fregoso Y, Nuñez-Alvarez CA, Llorente L.
    Lupus; 2016 Apr 06; 25(4):364-9. PubMed ID: 26466614
    [Abstract] [Full Text] [Related]

  • 11. The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.
    Jönsen A, Bengtsson AA, Nived O, Ryberg B, Truedsson L, Rönnblom L, Alm GV, Sturfelt G.
    Lupus; 2003 Apr 06; 12(11):846-50. PubMed ID: 14667101
    [Abstract] [Full Text] [Related]

  • 12. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P.
    Scand J Rheumatol; 2007 Apr 06; 36(6):442-7. PubMed ID: 18092265
    [Abstract] [Full Text] [Related]

  • 13. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
    Yoshio T, Hirata D, Onda K, Nara H, Minota S.
    J Rheumatol; 2005 Jan 06; 32(1):34-9. PubMed ID: 15630721
    [Abstract] [Full Text] [Related]

  • 14. Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus.
    Dellalibera-Joviliano R, Dos Reis ML, Cunha Fde Q, Donadi EA.
    J Rheumatol; 2003 Mar 06; 30(3):485-92. PubMed ID: 12610806
    [Abstract] [Full Text] [Related]

  • 15. Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases.
    Ichinose K, Arima K, Ushigusa T, Nishino A, Nakashima Y, Suzuki T, Horai Y, Nakajima H, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Motomura M, Kawakami A.
    Clin Immunol; 2015 Apr 06; 157(2):114-20. PubMed ID: 25656641
    [Abstract] [Full Text] [Related]

  • 16. [Clinical significance of neuro-reactive autoantibodies in neuro-psychiatric systemic lupus erythematosus].
    Lu XY, Ye S, Wang Y, Guo L, Chen XX, Fan W, Wang XD, Gu YY, Bao CD, Liu Q.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 19; 86(35):2462-6. PubMed ID: 17156673
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin.
    Katsumata Y, Harigai M, Kawaguchi Y, Fukasawa C, Soejima M, Takagi K, Tanaka M, Ichida H, Tochimoto A, Kanno T, Nishimura K, Kamatani N, Hara M.
    J Rheumatol; 2007 Oct 19; 34(10):2010-7. PubMed ID: 17896804
    [Abstract] [Full Text] [Related]

  • 18. Predictors of clinical outcomes in patients with neuropsychiatric systemic lupus erythematosus.
    Ichinose K, Arima K, Umeda M, Fukui S, Nishino A, Nakashima Y, Suzuki T, Horai Y, Koga T, Kawashiri SY, Iwamoto N, Fujikawa K, Aramaki T, Tamai M, Nakamura H, Sato S, Origuchi T, Kawakami A.
    Cytokine; 2016 Mar 19; 79():31-7. PubMed ID: 26745468
    [Abstract] [Full Text] [Related]

  • 19. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.
    Arinuma Y, Yanagida T, Hirohata S.
    Arthritis Rheum; 2008 Apr 19; 58(4):1130-5. PubMed ID: 18383393
    [Abstract] [Full Text] [Related]

  • 20. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.
    Trysberg E, Nylen K, Rosengren LE, Tarkowski A.
    Arthritis Rheum; 2003 Oct 19; 48(10):2881-7. PubMed ID: 14558094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.